Conclusion. Mefloquine – when used as IPTp for the prevention of malaria – shows promising activity against concomitant S. haematobiuminfection leading to an important reduction of egg excretion in pregnant women. Provided that further studies confirm these findings, the use of mefloquine may transform future IPTp programs into a two-pronged intervention addressing two of the most virulent parasitic infections in pregnant women in sub-Saharan Africa.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment